Literature DB >> 1382101

Immunogenic properties of multiple antigen peptide systems containing defined T and B epitopes.

S K Chai1, P Clavijo, J P Tam, F Zavala.   

Abstract

Immunization with chemically defined synthetic polymers, multiple Ag peptide (MAP) systems, containing T and B epitopes of the circumsporozoite protein of P. berghei induce high levels of circulating antibodies that are detectable several months after boosting. The anti-MAP secondary antibody response is characterized by an increase in the levels of circulating IgG and a concomitant decrease in the IgM levels. In vitro and in vivo experiments indicated that Th epitopes included in the MAP are recognized by T cells induced after immunization with the native protein and, also, that MAP-induced T cells can recognize the native protein. In addition to high levels of anti-B epitope antibodies, MAP immunization also induces antibodies against the T epitope. This anti-T epitope immune response does not affect the generation of the anti-B epitope antibodies. Immunization of different strains of mice revealed that the antibody response is consistent with the genetically restricted pattern of recognition of the T epitope. There are, however, significant differences in the levels of antibody responses observed among responder strains. The findings of this study indicate that MAP are potent immunogens capable of inducing immunologic memory and are, thus, good candidates for the development of subunit vaccines designed to induce high levels of circulating antibodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382101

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.

Authors:  Anahit Ghochikyan; Mikayel Mkrtichyan; Irina Petrushina; Nina Movsesyan; Adrine Karapetyan; David H Cribbs; Michael G Agadjanyan
Journal:  Vaccine       Date:  2005-12-05       Impact factor: 3.641

2.  Malaria vaccine based on self-assembling protein nanoparticles.

Authors:  Peter Burkhard; David E Lanar
Journal:  Expert Rev Vaccines       Date:  2015-10-15       Impact factor: 5.217

3.  A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.

Authors:  J Mauricio Calvo-Calle; Giane A Oliveira; Carol Othoro Watta; Jonathan Soverow; Carlos Parra-Lopez; Elizabeth H Nardin
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

4.  Identification of murine B-cell and T-cell epitopes of Escherichia coli outer membrane protein F with synthetic polypeptides.

Authors:  K M Williams; E C Bigley; R B Raybourne
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

5.  Use of monoclonal antibodies to facilitate identification, cloning, and purification of Chlamydia trachomatis hsp10.

Authors:  D LaVerda; G I Byrne
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

6.  Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes.

Authors:  D Grillot; D Valmori; P H Lambert; G Corradin; G Del Giudice
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

7.  How well can a T-cell epitope replace its parent carrier protein? A dose-response study.

Authors:  James S Cavenaugh; Hsu-Kun Wang; Cory Hansen; Richard S Smith; James N Herron
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

8.  Immunogenicity of epitope vaccines targeting different B cell antigenic determinants of human α-synuclein: feasibility study.

Authors:  Anahit Ghochikyan; Irina Petrushina; Hayk Davtyan; Armine Hovakimyan; Tommy Saing; Arpine Davtyan; David H Cribbs; Michael G Agadjanyan
Journal:  Neurosci Lett       Date:  2013-12-19       Impact factor: 3.046

9.  Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice.

Authors:  Irina Petrushina; Anahit Ghochikyan; Mikayel Mktrichyan; Gregory Mamikonyan; Nina Movsesyan; Hayk Davtyan; Archita Patel; Elizabeth Head; David H Cribbs; Michael G Agadjanyan
Journal:  J Neurosci       Date:  2007-11-14       Impact factor: 6.167

10.  Promiscuous peptides on the nontypeable Haemophilus influenzae P6 outer membrane protein.

Authors:  Yuka Nomura; Yusuke Abe; Yoshiya Ishida; Hiroya Kobayashi; Yasuaki Harabuchi
Journal:  J Clin Immunol       Date:  2008-04-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.